THEN & [NOW]
____   Celebrating 20+ Years of BioScience Colorado Magazine!
Foresight Diagnostics Grows from One Employee to a $275M Acquisition
T H E N : 
Our 2022-2023 issue featured 
Foresight Diagnostics after 
Cofounder and CEO Jake Chabon, 
Ph.D., moved the company from 
the Bay Area to Colorado. Some 
investors questioned the decision. 
Chabon saw strong scientific talent, 
greater capital efficiency, and a life 
sciences community where leaders 
shared ideas and helped one another. 
Foresight had raised $12.5 million and 
was building its blood-based cancer 
diagnostics technology at Fitzsimons 
Innovation Community in Aurora.
N OW: 
Foresight grew from one employee to more 
than 110 and raised more than $86 million. 
It expanded into a 13,000-square-foot CLIA-
certified lab and additional office space in 
Boulder. Its Foresight CLARITY™ test earned 
inclusion in NCCN clinical practice guidelines 
for B-cell lymphoma, accelerating demand. In 
December 2025, Natera acquired Foresight 
for $275 million upfront, with up to $175 
million in additional milestone payments. 
The combination gives Foresight access to 
Natera’s commercial and operational scale, 
with the goal of bringing its technology to 
more patients and more cancer types.
2026-27 BIOSCIENCE COLORADO     33
Colorado’s bioscience industry 
is changing the world. 
Denver International Airport (DEN) connects 
the bioscience community to the people, ideas, 
investment and markets that move it forward. 
flydenver.com
No one does __________________ like DEN.
Connectivity

View this content as a flipbook by clicking here.